Single-cell profiling reveals the trajectory of FOLR2-expressing tumor-associated macrophages to regulatory T cells in the progression of lung adenocarcinoma.


Journal

Cell death & disease
ISSN: 2041-4889
Titre abrégé: Cell Death Dis
Pays: England
ID NLM: 101524092

Informations de publication

Date de publication:
02 08 2023
Historique:
received: 30 12 2022
accepted: 25 07 2023
revised: 17 07 2023
medline: 4 8 2023
pubmed: 3 8 2023
entrez: 2 8 2023
Statut: epublish

Résumé

An immunosuppressive microenvironment enriched with regulatory CD4

Identifiants

pubmed: 37532692
doi: 10.1038/s41419-023-06021-6
pii: 10.1038/s41419-023-06021-6
pmc: PMC10397223
doi:

Substances chimiques

Folate Receptor 2 0
Ligands 0
Chemokines 0
Forkhead Transcription Factors 0
FOLR2 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

493

Informations de copyright

© 2023. The Author(s).

Références

Br J Cancer. 2019 Jan;120(1):45-53
pubmed: 30413828
Dig Dis. 2010;28(1):31-44
pubmed: 20460888
Crit Rev Immunol. 2014;34(2):103-20
pubmed: 24940911
Clin Dev Immunol. 2012;2012:925135
pubmed: 22474485
Nat Commun. 2019 Jul 5;10(1):2978
pubmed: 31278276
Cancer Discov. 2021 Oct;11(10):2506-2523
pubmed: 33972311
Front Immunol. 2020 May 15;11:940
pubmed: 32499786
Nature. 2020 Nov;587(7835):619-625
pubmed: 33208946
Annu Rev Immunol. 2012;30:531-64
pubmed: 22224781
Front Cell Dev Biol. 2021 Mar 18;9:648806
pubmed: 33869203
Eur Respir J. 2015 Dec;46(6):1762-72
pubmed: 26541534
APMIS. 2017 Nov;125(11):945-956
pubmed: 28836736
Cell. 2020 Oct 15;183(2):377-394.e21
pubmed: 32976798
Nat Immunol. 2015 Nov;16(11):1174-84
pubmed: 26414764
Nat Immunol. 2013 Mar;14(3):230-7
pubmed: 23334790
Cancer Immunol Res. 2014 Dec;2(12):1125-31
pubmed: 25480554
Science. 2003 Feb 14;299(5609):1057-61
pubmed: 12522256
Cell. 2014 Apr 24;157(3):714-25
pubmed: 24766814
Cancer Immunol Res. 2022 Nov 2;10(11):1340-1353
pubmed: 36122412
Clin Transl Med. 2021 Jan;11(1):e253
pubmed: 33463049
J Immunol Res. 2022 Apr 22;2022:4355386
pubmed: 35497874
JCI Insight. 2017 Aug 17;2(16):
pubmed: 28814673
Nat Methods. 2016 Apr;13(4):329-332
pubmed: 26950746
Genes Dev. 2018 Oct 1;32(19-20):1267-1284
pubmed: 30275043
Cell. 2022 Mar 31;185(7):1189-1207.e25
pubmed: 35325594
Front Immunol. 2019 Dec 03;10:2839
pubmed: 31849995
Cancers (Basel). 2021 Apr 13;13(8):
pubmed: 33924428
Nat Methods. 2017 Oct;14(10):979-982
pubmed: 28825705
Arch Pharm Res. 2016 Nov;39(11):1530-1536
pubmed: 27778276
Signal Transduct Target Ther. 2020 Jan 22;5(1):6
pubmed: 32296026
J Immunol. 2002 Oct 15;169(8):4183-9
pubmed: 12370347
Nat Commun. 2020 May 8;11(1):2285
pubmed: 32385277
Nat Methods. 2017 Nov;14(11):1083-1086
pubmed: 28991892
Oncogene. 2021 Dec;40(50):6748-6758
pubmed: 34663877
Immunology. 2013 Feb;138(2):105-15
pubmed: 23216602
Nat Med. 2018 May;24(5):541-550
pubmed: 29686425
Immunity. 2016 Nov 15;45(5):1135-1147
pubmed: 27851914
Front Endocrinol (Lausanne). 2021 Feb 01;11:624122
pubmed: 33597928
Mod Pathol. 2022 Sep;35(9):1181-1192
pubmed: 35641658
Int J Clin Exp Pathol. 2020 May 01;13(5):880-888
pubmed: 32509058
Sci Rep. 2018 Mar 20;8(1):4899
pubmed: 29559701
Cell Rep. 2021 Dec 21;37(12):110132
pubmed: 34936871
Nat Commun. 2021 Nov 11;12(1):6500
pubmed: 34764257
Nat Rev Drug Discov. 2022 Jul;21(7):529-540
pubmed: 35701637
Transl Lung Cancer Res. 2014 Feb;3(1):15-22
pubmed: 25806277
Front Immunol. 2013 Jul 16;4:197
pubmed: 23874342
Clin Cancer Res. 2020 Aug 1;26(15):3901-3907
pubmed: 32332013
Cancer Res. 2009 Dec 15;69(24):9395-403
pubmed: 19951991
FEBS J. 2018 Aug;285(16):2944-2971
pubmed: 29637711
J Intern Med. 2021 May;289(5):629-635
pubmed: 33340175
Nat Med. 2018 Aug;24(8):1277-1289
pubmed: 29988129
J Exp Med. 2003 Dec 15;198(12):1875-86
pubmed: 14676299
Nat Rev Immunol. 2017 Sep;17(9):559-572
pubmed: 28555670
Nat Commun. 2021 May 11;12(1):2722
pubmed: 33976164
Mediators Inflamm. 2014;2014:170381
pubmed: 24966464
Int J Mol Sci. 2018 Apr 23;19(4):
pubmed: 29690599
J Clin Invest. 2001 Jun;107(11):1357-64
pubmed: 11390417
Nat Protoc. 2020 Apr;15(4):1484-1506
pubmed: 32103204
J Thorac Oncol. 2015 Sep;10(9):1243-1260
pubmed: 26291008
Ann Surg Oncol. 2012 Jul;19(7):2264-71
pubmed: 22350599

Auteurs

Chan Xiang (C)

Department of Pathology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200030, China.

Min Zhang (M)

Novogene Co., Ltd., Beijing, 100015, China.

Zhanxian Shang (Z)

Department of Pathology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200030, China.

Shengnan Chen (S)

Department of Pathology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200030, China.

Jikai Zhao (J)

Department of Pathology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200030, China.

Bowen Ding (B)

Department of Pathology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200030, China.

Dong Jiang (D)

Novogene Co., Ltd., Beijing, 100015, China.

Qian Zhu (Q)

Department of Pathology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200030, China.

Haohua Teng (H)

Department of Pathology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200030, China.

Lei Zhu (L)

Department of Pathology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200030, China.

Jinchen Shao (J)

Department of Pathology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200030, China.

Ruiying Zhao (R)

Department of Pathology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200030, China.

Min Ye (M)

Department of Pathology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200030, China.

Yang Yu (Y)

Novogene Co., Ltd., Beijing, 100015, China. yuyang@novogene.com.

Yuchen Han (Y)

Department of Pathology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200030, China. ychan@cmu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH